588 Results

People

  1. Begg
    Begg
  2. Panageas
    Panageas
  3. Norton
    Norton
  4. Hudis
    Hudis
  5. Orlow
    Orlow
  6. Chapman
    Chapman
  7. Seshan
    Seshan
  8. Shen
    Shen
  9. Cheung
    Cheung
  10. Busam
    Busam

Groups

  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (588)
  2. Biostatistics Service (588)
  3. Epidemiology and Biostatistics (588)
  4. Population Sciences Research Program (421)
  5. Sloan Kettering Institute Faculty (340)
  6. Department of Medicine (308)
  7. Molecular Pharmacology and Chemistry Program Faculty (302)
  8. GSK Faculty (282)
  9. Solid Tumor Oncology Division (274)
  10. Health Outcomes Research Group (249)
  1. "Journal article"
  2. "Biostatistics Service"
  3. "Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center "
Formats
  1. Journal Article (588)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (588)
  2. Biostatistics Service (588)
  3. Epidemiology and Biostatistics (588)
  4. Population Sciences Research Program (421)
  5. Sloan Kettering Institute Faculty (340)
  6. Department of Medicine (308)

More Groups

People
  1. Colin Begg (245)
  2. Katherine Panageas (102)
  3. Larry Norton (84)
  4. Clifford Hudis (61)
  5. Paul Chapman (57)
  6. Charles Rudin (55)

More People

Years
  1. 2024 (3)
  2. 2023 (21)
  3. 2022 (24)
  4. 2021 (37)
  5. 2020 (24)
  6. 2019 (30)

More Years

Publications
  1. Journal of Clinical Oncology (58)
  2. Clinical Cancer Research (55)
  3. JNCI: Journal of the National Cancer Institute (23)
  4. Statistics in Medicine (21)
  5. Cancer (20)
  6. Cancer Epidemiology Biomarkers and Prevention (14)

More Publications

Publishers
  1. American Association for Cancer Research (87)
  2. American Society of Clinical Oncology (64)
  3. Oxford University Press (56)
  4. Wiley Blackwell (45)
  5. Elsevier Inc. (34)
  6. Nature Publishing Group (32)

More Publishers

Results (588)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): An open-label, randomised, controlled, phase 2 study
    Journal Article

    Tsai, C. J.; Yang, J. T.; Shaverdian, N.; Patel, J.; Shepherd, A. F.; Eng, J.; Guttmann, D.; Yeh, R.; Gelblum, D. Y.; Namakydoust, A.; more...
    Lancet (2024)

    Fulltext@MSK | Save
  • Preoperative immune checkpoint inhibition and cryoablation in early-stage breast cancer
    Journal Article

    Comen, E.; Budhu, S.; Elhanati, Y.; Page, D.; Rasalan-Ho, T.; Ritter, E.; Wong, P.; Plitas, G.; Patil, S.; Brogi, E.; more...
    iScience (2024)

    Fulltext@MSK | Save
  • Adaptation of a mutual exclusivity framework to identify driver mutations within oncogenic pathways
    Journal Article

    Wang, X.; Kostrzewa, C.; Reiner, A.; Shen, R.; Begg, C.
    American Journal of Human Genetics (2024)

    Fulltext@MSK | Save
  • Pathway alterations in stage II/III primary melanoma
    Journal Article

    Kostrzewa, C. E.; Luo, L.; Arora, A.; Seshan, V. E.; Ernstoff, M. S.; Edmiston, S. N.; Conway, K.; Gorlov, I.; Busam, K.; Orlow, I.; more...
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Outcomes of combination platinum-doublet chemotherapy and anti-PD(L)-1 blockade in KRAS(G12C) mutant non-small cell lung cancer
    Journal Article

    Elkrief, A.; Riccuiti, B.; Alessi, J. V.; Fei, T.; Kalvin, H. L.; Egger, J. V.; Rizvi, H.; Thummalapalli, R.; Lamberti, G.; Plodkowski, A.; more...
    The Oncologist (2023)

    Fulltext@MSK | Save
  • Association of functional, inherited vitamin D-binding protein variants with melanoma-specific death
    Journal Article

    Gibbs, D. C.; Thomas, N. E.; Kanetsky, P. A.; Luo, L.; Busam, K. J.; Cust, A. E.; Anton-Culver, H.; Gallagher, R. P.; Zanetti, R.; Rosso, S.; more...
    JNCI Cancer Spectrum (2023)

    Fulltext@MSK | Save
  • Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: A cohort study
    Journal Article

    Elkrief, A.; Alessi, J. M. V.; Ricciuti, B.; Brown, S.; Rizvi, H.; Preeshagul, I. R.; Wang, X.; Pecci, F.; Di Federico, A.; Lamberti, G.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • The use of single-timepoint images to link administered radioiodine activity (MBq) to a prescribed lesion radiation-absorbed dose (cGy): A regression-based prediction interval tool for the management of well-differentiated thyroid cancer patients
    Journal Article

    Mauguen, A.; Grewal, R. K.; Augensen, F.; Abusamra, M.; Mahajan, S.; Jayaprakasam, V. S.; Osborne, J.; Haque, S.; Wong, B. Z. Y.; Ghossein, R. A.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2023)

    Fulltext@MSK | Save
  • Predicting cancer risk from germline whole-exome sequencing data using a novel context-based variant aggregation approach
    Journal Article

    Guan, Z.; Begg, C. B.; Shen, R.
    Cancer Research Communications (2023)

    Fulltext@MSK | Save
  • Randomized phase 2 placebo-controlled trial of nintedanib for the treatment of radiation pneumonitis
    Journal Article

    Rimner, A.; Moore, Z. R.; Lobaugh, S.; Geyer, A.; Gelblum, D. Y.; Abdulnour, R. E. E.; Shepherd, A. F.; Shaverdian, N.; Wu, A. J.; Cuaron, J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2023)

    Fulltext@MSK | Save